Nandabalan Krishnan - Insider Non-Derivative Transactions at BioXcel Therapeutics, Inc. (BTAI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 6, 2023, Nandabalan Krishnan's relationship to BioXcel Therapeutics, Inc. (BTAI) is Director,TenPercentOwner, and currently has 60,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BTAI insiders.
Data Source: SEC.
Nandabalan Krishnan - Insider Non-Derivative Transactions of BTAI Common Stock
Nandabalan Krishnan - Insider Non-Derivative Transactions at BTAI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 7, 2023 | Sell -- (Common Stock) | 60000 | 17.32 | 0 |
| Apr 7, 2023 | M -- (Common Stock) | 60000 | 0.41 | 60000 |
| Jan 6, 2023 | Sell -- (Common Stock) | 800 | 22.93 | 0 |
| Jan 6, 2023 | Sell -- (Common Stock) | 25089 | 22.32 | 800 |
| Jan 6, 2023 | M -- (Common Stock) | 25889 | 0.41 | 25889 |
| Jan 5, 2023 | Sell -- (Common Stock) | 9821 | 22.21 | 0 |
| Jan 5, 2023 | Sell -- (Common Stock) | 24290 | 21.59 | 9821 |
| Jan 5, 2023 | M -- (Common Stock) | 34111 | 0.41 | 34111 |
| Nov 16, 2022 | G -- (Common Stock) | 291097 | 0 | 8546750 |
| Nov 16, 2022 | G -- (Common Stock) | 145549 | 0 | 8546750 |